Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Institut Georges Lopez manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently shows 1 pending office action. This activity involves 1 distinct examiner and 1 distinct art unit, reflecting a singular focus for the company's active patent prosecution. Such a centralized profile suggests that the institute is currently pursuing a specific technological advancement within a specialized biotechnology group.
CORDAS, EMILY ANN is the busiest examiner for this portfolio, with 1 busiest examiner pending office action. This single action accounts for the total 1 pending office action reported for the company. With 1 distinct examiner and 1 distinct art unit, the company's current interactions with the patent office are centralized under 1 official. This means that the company's current prosecution progress is entirely dependent on the review and feedback of this 1 examiner, which is a common scenario for portfolios with a highly specific technical focus.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CORDAS, EMILY ANN | 1 | 50.9% | +57.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17538222 | SOLUTION FOR PRESERVING AND/OR RINSING AN ORGAN TO BE TRANSPLANTED | CORDAS, EMILY ANN | 32d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17538222 | SOLUTION FOR PRESERVING AND/OR RINSING AN ORGAN TO BE TRANSPLANTED | CORDAS, EMILY ANN | 32d overdue |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17538222 | SOLUTION FOR PRESERVING AND/OR RINSING AN ORGAN TO BE TRANSPLANTED | CORDAS, EMILY ANN | 1632 | §103§112 | Non-Final OA | 32d overdue | Pending | Nov 30, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialInstitut Georges Lopez has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Emily Ann Cordas has the most, with 1 of Institut Georges Lopez's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
